ANDANJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Lifecycle
Pre-Launch
Clinical Trials
1
Clinical Trials (1)
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer
Started Feb 2020
26 enrolled
Prostate Cancer